Get started
Author

Maaz Tahir Sadiq

Observed names: M. Sadiq, M. T. Sadiq, Maaz Sadiq, Maaz T Sadiq, Maaz T. Sadiq
ORCID: 0000-0002-5906-8363
Observed ORCID: 0000-0002-5906-8363
OpenAlex ID: A5086375388
HTLV-1 viral RNA is detected rarely in plasma of HTLV-1 infected subjects
2015 · Maria Antonietta Demontis, Maaz Tahir Sadiq, et al. · Journal of Medical Virology · 59
Towards Personalized Management of Ovarian Cancer
2022 · Mashael Algethami, Sanat Kulkarni, et al. · Cancer Management and Research · 15
PDF
Werner Syndrome Protein Expression in Breast Cancer
2020 · Constantinos Savva, Maaz Sadiq, et al. · Clinical Breast Cancer · 15
PDF
ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
2019 · Tarek M. A. Abdel-Fatah, Reem Ali, et al. · Cancers · 13
PDF
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 · Alessandra Mangone, Barbara Altieri, et al. · European Journal of Endocrinology · 3
Precision medicine for the treatment of triple negative breast cancer: opportunities and challenges
2021 · Maaz Tahir Sadiq, Juliette Servante, et al. · Expert Review of Precision Medicine and Drug Development · 1
Chapter 26. Evolving DNA Repair Targets for Cancer Therapy
2020 · M. T. Sadiq, S. Madhusudan · Chemical biology · 1
Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumors
2019 · Adel Alblihy, Katia A. Mesquita, et al. · Expert Review of Precision Medicine and Drug Development · 1
Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK
2026 · R. Batool, M. Julve, et al. · Clinical Oncology
Real-world experience of the KEYNOTE-522 Regimen in Early Triple-Negative Breast Cancer at University Hospitals Birmingham
2026 · Zohaib Sajid, Kabo Mohamed, et al. · Clinical Oncology
Works count: 10
Citation count: 108
H-index: 4
I10-index: 4
Year
Topic
Type